Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2005, Vol. 10 ›› Issue (10): 1096-1099.

Previous Articles     Next Articles

Group I and III metabotropic glutamate receptors agonists reverse 1-methyl-4-phenylpyridinium-induced glutamate uptake inhibition in C6 glioma cells

WANG Fang, YAO Hong-hong, HU Gang   

  1. Department of Pharmacology & Neurobiology, Nanjing Medical Uniersity, Nanjing 210029, China
  • Received:2005-09-09 Revised:2005-09-30 Published:2020-11-23

Abstract: AIM: To study the effect of group II and Ill metabotropic glutamate receptors (mGluRs) agonistson 1-methyl-4-phenylpyridinium (MPP+) induced gluta-mate uptake inhibition in C6 glioma cell.METHODS: The glutamate uptake into astrocytes was measured by using radio-ligand binding assay method.RESULTS: It was shown that Group II mGluRs agonist (2 ‘S, 2'R, 3'R)-2-(2 ‘ 3'-dicarboxycyclopropyl glycine (DCG-IV(100μmol·L-1) and Group II mGluRs agonist L (+)-2amino-4-phosphonobutyric acid (L-AP4) (100μmol·L-1) significantly reversed Mpp+-induced gluta-mate uptake inhibition. Furthermore, the enhancementeffects of DCG-IV and L-AP4 were blocked by their re-spective antagonists, (RS)-1-Amino-5-phosphonoinan-1carboxylic acid (APICA and (RS)-α-methylserine-Ophosphate (MSOP).CONCLUSION: Group II and Ill mGluRs agonists produce neuroprotective effects byenhancing the activity of glutamate transporters.

Key words: metabotropic glutamate receptors, MPP+, C6 glioma cells, glutamate uptake

CLC Number: